We are terminating coverage of Epigenomics AG. Investors should not rely on any previous research or forecasts.

31 Oct 2019
Termination of coverage

Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Termination of coverage
Epigenomics AG (0QXH:LON) | 0 0 0.0% | Mkt Cap: 126.0m
- Published:
31 Oct 2019 -
Author:
Martin Piehlmeier -
Pages:
5 -
We are terminating coverage of Epigenomics AG. Investors should not rely on any previous research or forecasts.